Emma Walmsley, GSK CEO (Kevin Dietsch/Pool via CNP/Alamy)
GSK doubles down on vaccines, HIV meds as CEO Emma Walmsley touts 'landmark' 2022
The step change that Emma Walmsley promised at GSK is here, and the CEO has financial results that surpassed forecasts to show for it. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
